Update on the diagnosis and management of pulmonary embolism

British Journal of Haematology

Volumn 131, Issue 3, 2005, Pages 301-312

  Garcia, David ^a   Ageno, Walter ^b   Libby, Edward ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Diagnosis; Pulmonary embolism; Treatment; Venous thromboembolism

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ARGATROBAN; DALTEPARIN; DESULFATOHIRUDIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HIRUDIN; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; PENTASACCHARIDE; STREPTOKINASE; UROKINASE; WARFARIN; XIMELAGATRAN;

ANTICOAGULATION; BLEEDING; BLOOD CLOT LYSIS; BLOOD FILTER; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG EFFICACY; DRUG HALF LIFE; ECHOCARDIOGRAPHY; EMBOLECTOMY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERKALEMIA; INFERIOR CAVA VEIN; LONG TERM CARE; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG VENTILATION PERFUSION RATIO; PATHOPHYSIOLOGY; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; REVIEW; SCINTISCANNING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY; VENOUS THROMBOEMBOLISM; ALGORITHM; FEMALE; FIBRINOLYTIC THERAPY; METHODOLOGY; PREGNANCY COMPLICATION;

ALGORITHMS; ANTICOAGULANTS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULMONARY EMBOLISM; THROMBOLYTIC THERAPY;

EID: 31644443914     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05752.x     Document Type: Review

References (125)

1. Agnelli G. Prandoni P. Becattini C. Silingardi M. Taliani M.R. Miccio M. Imberti D. Poggio R. Ageno W. Pogliani E. Porro F. Zonzin P. (2003) Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Annals of Internal Medicine, 139, 19 25.
2. Ahmad S. Walenga J.M. Jeske W.P. Cella G. Fareed J. (1999) Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome. Clinical and Applied Thrombosis/Hemostasis, 5 (Suppl. 1 S32 S37 Giangola G. (1999) Deep venous thrombosis and pulmonary embolism: diagnosis, prophylaxis, and treatment. Annals of Vascular Surgery, 13, 318 327.
3. Alikhan R. Cohen A.T. Combe S. Samama M.M. Desjardins L. Eldor A. Janbon C. Leizorovicz A. Olsson C.G. Turpie A.G. (2004) Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Archives of Internal Medicine, 164, 963 968.
4. Amiral J. Lormeau J.C. Marfaing-Koka A. Vissac A.M. Wolf M. Boyer-Neumann C. Tardy B. Herbert J.M. Meyer D. (1997) Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia. Blood Coagulation & Fibrinolysis, 8, 114 117 Olsen J. (1998) The cumulative incidence of venous thromboembolism during pregnancy and puerperium - an 11 year Danish population-based study of 63,300 pregnancies. Acta Obstetricia et Gynecologica Scandinavica, 77, 170 173.
5. Anderson D.R. Wells P.S. (2000) d-dimer for the diagnosis of venous thromboembolism. Current Opinion in Hematology, 7, 296 301.
6. Anderson F.A. Jr.. Wheeler H.B. Goldberg R.J. Hosmer D.W. Patwardhan N.A. Jovanovic B. Forcier A. Dalen J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine, 151, 933 938.
7. Arcasoy S.M. Kreit J.W. (1999) Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence. Chest, 115, 1695 1707.
8. Atrash H.K. Koonin L.M. Lawson H.W. Franks A.L. Smith J.C. (1990) Maternal mortality in the United States, 1979-1986. Obstetrics and Gynecology, 76, 1055 1060.
9. Badmanaban B. Sachithanandan A. Hunter I. Graham A. Sarsam M. (2003) Massive pulmonary embolism due to late-onset heparin-induced thrombocytopenia following coronary artery bypass graft surgery: successful treatment with lepirudin. Journal of Cardiac Surgery, 18, 316 318.
10. Barritt D.W. Jordan S.C. (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet, 1, 1309 1312.
11. Bates S.M. Greer I.A. Hirsh J. Ginsberg J.S. (2004) Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 627S 644S.
12. Bauer K.A. Eriksson B.I. Lassen M.R. Turpie A.G. (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. The New England Journal of Medicine, 345, 1305 1310.
13. van Beek E.J. Reekers J.A. Batchelor D.A. Brandjes D.P. Buller H.R. (1996) Feasibility, safety and clinical utility of angiography in patients with suspected pulmonary embolism. European Radiology, 6, 415 419.
14. Begelman S.M. Deitcher S.R. (2002) Outpatient management of venous thromboembolic disease with subcutaneous lepirudin: a case report. Journal of Thrombosis and Thrombolysis, 13, 183 185.
15. Brandjes D.P. Heijboer H. Buller H.R. de Rijk M. Jagt H. ten Cate J.W. (1992) Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. The New England Journal of Medicine, 327, 1485 1489.
16. Breddin H.K. Hach-Wunderle V. Nakov R. Kakkar V.V. (2001) Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. The New England Journal of Medicine, 344, 626 631.
17. Buller H.R. Davidson B.L. Decousus H. Gallus A. Gent M. Piovella F. Prins M.H. Raskob G. den Berg-Segers A.E. Cariou R. Leeuwenkamp O. Lensing A.W. (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. The New England Journal of Medicine, 349, 1695 1702.
18. Buller H.R. Agnelli G. Hull R.D. Hyers T.M. Prins M.H. Raskob G.E. (2004) Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126 (Suppl. 3 401S 428S Jr.. Hobbins T.E. (1992) The clinical course of pulmonary embolism. The New England Journal of Medicine, 326, 1240 1245.
19. Chagnon I. Bounameaux H. Aujesky D. Roy P.M. Gourdier A.L. Cornuz J. Perneger T. Perrier A. (2002) Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. The American Journal of Medicine, 113, 269 275.
20. Cheely R. McCartney W.H. Perry J.R. Delany D.J. Bustad L. Wynia V.H. Griggs T.R. (1981) The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. The American Journal of Medicine, 70, 17 22.
21. Cogo A. Bernardi E. Prandoni P. Girolami B. Noventa F. Simioni P. Girolami A. (1994) Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Archives of Internal Medicine, 154, 164 168.
22. Dalen J.E. Alpert J.S. Hirsch J. (1997) Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Archives of Internal Medicine, 157, 2550 2556.
23. Davidson B.L. (1999) Differentiation of low molecular weight heparins in treatment of acute deep vein thrombosis. Seminars in Thrombosis and Hemostasis, 25 (Suppl. 3 107 112.
24. Decousus H. Leizorovicz A. Parent F. Page Y. Tardy B. Girard P. Laporte S. Faivre R. Charbonnier B. Barral F.G. Huet Y. Simonneau G. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. The New England Journal of Medicine, 338, 409 415.
25. Diehl J.L. Meyer G. Igual J. Collignon M.A. Giselbrecht M. Even P. Sors H. (1992) Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism. The American Journal of Cardiology, 70, 1477 1480.
26. Douketis J.D. Kearon C. Bates S. Duku E.K. Ginsberg J.S. (1998) Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA, 279, 458 462.
27. Douketis J.D. Leeuwenkamp O. Grobara P. Johnston M. Sohne M. Ten Wolde M. Buller H. (2005) The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism. Journal of Thrombosis and Haemostasis, 3, 508 513.
28. Drucker E.A. Rivitz S.M. Shepard J.A. Boiselle P.M. Trotman-Dickenson B. Welch T.J. Maus T.P. Miller S.W. Kaufman J.A. Waltman A.C. McLoud T.C. Athanasoulis C.A. (1998) Acute pulmonary embolism: assessment of helical CT for diagnosis. Radiology, 209, 235 241.
29. Eichinger S. (2003) d-dimer testing in pregnancy. Pathophysiology of Haemostasis and Thrombosis, 33, 327 329.
30. Eldor A. (2001) Thrombophilia and its treatment in pregnancy. Journal of Thrombosis and Thrombolysis, 12, 23 30.
31. Eriksson B.I. Bauer K.A. Lassen M.R. Turpie A.G. (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. The New England Journal of Medicine, 345, 1298 1304.
32. Eriksson B.I. Agnelli G. Cohen A.T. Dahl O.E. Lassen M.R. Mouret P. Rosencher N. Kalebo P. Panfilov S. Eskilson C. Andersson M. Freij A. (2003) The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. Journal of Thrombosis and Haemostasis, 1, 2490 2496.
33. European Society of Cardiology (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. European Heart Journal, 21, 1301 1336.
34. Fiessinger J.N. Huisman M.V. Davidson B.L. Bounameaux H. Francis C.W. Eriksson H. Lundstrom T. Berkowitz S.D. Nystrom P. Thorsen M. Ginsberg J.S. (2005) Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA, 293, 681 689.
35. Francis C.W. Berkowitz S.D. Comp P.C. Lieberman J.R. Ginsberg J.S. Paiement G. Peters G.R. Roth A.W. McElhattan J. Colwell C.W. Jr.. (2003) Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. The New England Journal of Medicine, 349, 1703 1712.
36. Gallus A.S. (1994) Anticoagulants and antiplatelet drugs. The Medical Journal of Australia, 160, 78 82.
37. Geerts W.H. Heit J.A. Clagett G.P. Pineo G.F. Colwell C.W. Anderson F.A. Jr.. Wheeler H.B. (2001) Prevention of venous thromboembolism. Chest, 119 (Suppl. 1 132S 175S.
38. Geerts W.H. Pineo G.F. Heit J.A. Bergqvist D. Lassen M.R. Colwell C.W. Ray J.G. (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126 (Suppl. 3 338S 400S 1828.
39. Goldhaber S.Z. (1992) Evolving concepts in thrombolytic therapy for pulmonary embolism. Chest, 101, 183S 185S.
40. Goldhaber S.Z. (2002) Thrombolysis for pulmonary embolism. The New England Journal of Medicine, 347, 1131 1132.
41. Goldhaber S.Z. Hennekens C.H. Evans D.A. Newton E.C. Godleski J.J. (1982) Factors associated with correct antemortem diagnosis of major pulmonary embolism. The American Journal of Medicine, 73, 822 826.
42. Goldhaber S.Z. Haire W.D. Feldstein M.L. Miller M. Toltzis R. Smith J.L. Taveira da Silva A.M. Come P.C. Lee R.T. Parker J.A. (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet, 341, 507 511.
43. Goldhaber S.Z. Visani L. De Rosa M. (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 353, 1386 1389.
44. Greenfield L.J. Rutherford R.B. (1999) Recommended reporting standards for vena caval filter placement and patient follow-up. Vena Caval Filter Consensus Conference. Journal of Vascular and Interventional Radiology, 10, 1013 1019.
45. Greer I.A. (1999) Thrombosis in pregnancy: maternal and fetal issues. Lancet, 353, 1258 1265.
46. Grifoni S. Olivotto I. Cecchini P. Pieralli F. Camaiti A. Santoro G. Conti A. Agnelli G. Berni G. (2000) Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation, 101, 2817 2822.
47. Gurewich V. (2005) Ximelagatran - promises and concerns. JAMA, 293, 736 739.
48. Hamel E. Pacouret G. Vincentelli D. Forissier J.F. Peycher P. Pottier J.M. Charbonnier B. (2001) Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest, 120, 120 125.
49. Heit J.A. Silverstein M.D. Mohr D.N. Petterson T.M. O'Fallon W.M. Melton L.J. III. (1999) Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Archives of Internal Medicine, 159, 445 453.
50. Heit J.A. Silverstein M.D. Mohr D.N. Petterson T.M. Lohse C.M. O'Fallon W.M. Melton L.J. III. (2001) The epidemiology of venous thromboembolism in the community. Thrombosis and Haemostasis, 86, 452 463.
51. Hirsh J. Hoak J. (1996) Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation, 93, 2212 2245.
52. Hull R.D. Hirsh J. Carter C.J. Jay R.M. Dodd P.E. Ockelford P.A. Coates G. Gill G.J. Turpie A.G. Doyle D.J. Buller H.R. Raskob G.E. (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Annals of Internal Medicine, 98, 891 899.
53. Hull R.D. Raskob G.E. Ginsberg J.S. Panju A.A. Brill-Edwards P. Coates G. Pineo G.F. (1994) A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Archives of Internal Medicine, 154, 289 297.
54. Hyers T.M. Hull R.D. Weg J.G. (1986) Antithrombotic therapy for venous thromboembolic disease. Chest, 89, 26S 35S.
55. Hyers T.M. Agnelli G. Hull R.D. Morris T.A. Samama M. Tapson V. Weg J.G. (2001) Antithrombotic therapy for venous thromboembolic disease. Chest, 119, 176S 193S.
56. Kanter D.S. Mikkola K.M. Patel S.R. Parker J.A. Goldhaber S.Z. (1997) Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest, 111, 1241 1245.
57. Kearon C. (2003) Natural history of venous thromboembolism. Circulation, 107, I22 130.
58. Kearon C. Gent M. Hirsh J. Weitz J. Kovacs M.J. Anderson D.R. Turpie A.G. Green D. Ginsberg J.S. Wells P. MacKinnon B. Julian J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. The New England Journal of Medicine, 340, 901 907.
59. Konstantinides S. (2004) Should thrombolytic therapy be used in patients with pulmonary embolism American Journal of Cardiovascular Drugs, 4, 69 74.
60. Konstantinides S. Geibel A. Heusel G. Heinrich F. Kasper W. (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. The New England Journal of Medicine, 347, 1143 1150.
61. Koren-Michowitz M. Avni B. Michowitz Y. Moravski G. Efrati S. Golik A. (2004) Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study. Pharmacoepidemiology and Drug Safety, 13, 299 302.
62. Kovacs M.J. Anderson D. Morrow B. Gray L. Touchie D. Wells P.S. (2000) Outpatient treatment of pulmonary embolism with dalteparin. Thrombosis and Haemostasis, 83, 209 211.
63. Kruger S. Graf J. Merx M.W. Koch K.C. Kunz D. Hanrath P. Janssens U. (2004) Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. American Heart Journal, 147, 60 65.
64. Kruip M.J. Slob M.J. Schijen J.H. van der Heul C. Buller H.R. (2002) Use of a clinical decision rule in combination with d-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism: a prospective management study. Archives of Internal Medicine, 162, 1631 1635.
65. Lassen M.R. Bauer K.A. Eriksson B.I. Turpie A.G. (2002) Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet, 359, 1715 1720.
66. Lee A.Y. Levine M.N. Baker R.I. Bowden C. Kakkar A.K. Prins M. Rickles F.R. Julian J.A. Haley S. Kovacs M.J. Gent M. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of Medicine, 349, 146 153.
67. Lim A.Y. Parr D.G. Stableforth D.E. Fellows M. Fontaine R. Fegan C.D. (2003) Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin. European Journal of Internal Medicine, 14, 89 93
68. Morpurgo M. (1997) False negatives and ''false positives" in acute pulmonary embolism: a clinical-postmortem comparison. Cardiologia, 42, 205 210.
69. McConnell M.V. Solomon S.D. Rayan M.E. Come P.C. Goldhaber S.Z. Lee R.T. (1996) Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. The American Journal of Cardiology, 78, 469 473.
70. Merli G. Spiro T.E. Olsson C.G. Abildgaard U. Davidson B.L. Eldor A. Elias D. Grigg A. Musset D. Rodgers G.M. Trowbridge A.A. Yusen R.D. Zawilska K. (2001) Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Annals of Internal Medicine, 134, 191 202.
71. Meyer G. Tamisier D. Sors H. Stern M. Vouhe P. Makowski S. Neveux J.Y. Leca F. Even P. (1991) Pulmonary embolectomy: a 20-year experience at one center. The Annals of Thoracic Surgery, 51, 232 236.
72. Meyer T. Binder L. Hruska N. Luthe H. Buchwald A.B. (2000) Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. Journal of the American College of Cardiology, 36, 1632 1636.
73. Miniati M. Monti S. Pratali L. Di Ricco G. Marini C. Formichi B. Prediletto R. Michelassi C. Di Lorenzo M. Tonelli L. Pistolesi M. (2001) Value of transthoracic echocardiography in the diagnosis of pulmonary embolism: results of a prospective study in unselected patients. The American Journal of Medicine, 110, 528 535.
74. Moores L.K. Jackson W.L. Jr.. Shorr A.F. Jackson J.L. (2004) Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Annals of Internal Medicine, 141, 866 874.
75. Musset D. Parent F. Meyer G. Maitre S. Girard P. Leroyer C. Revel M.P. Carette M.F. Laurent M. Charbonnier B. Laurent F. Mal H. Nonent M. Lancar R. Grenier P. Simonneau G. (2002) Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study. Lancet, 360, 1914 1920.
76. Nazario R. Delorenzo L.J. Maguire A.G. (2002) Treatment of venous thromboembolism. Cardiology in Review, 10, 249 259.
77. Nendaz M.R. Bandelier P. Aujesky D. Cornuz J. Roy P.M. Bounameaux H. Perrier A. (2004) Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thrombosis and Haemostasis, 91, 1232 1236.
78. Novelline R.A. Baltarowich O.H. Athanasoulis C.A. Waltman A.C. Greenfield A.J. McKusick K.A. (1978) The clinical course of patients with suspected pulmonary embolism and a negative pulmonary arteriogram. Radiology, 126, 561 567.
79. Offner P.J. Hawkes A. Madayag R. Seale F. Maines C. (2003) The role of temporary inferior vena cava filters in critically ill surgical patients. Archives of Surgery, 138, 591 594 discussion 594-595.
80. Ogren M. Bergqvist D. Eriksson H. Lindblad B. Sternby N.H. (2005) Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsies. European Heart Journal, 26, 1108 1114.
81. Pengo V. Lensing A.W. Prins M.H. Marchiori A. Davidson B.L. Tiozzo F. Albanese P. Biasiolo A. Pegoraro C. Iliceto S. Prandoni P. (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. The New England Journal of Medicine, 350, 2257 2264.
82. Perrier A. Desmarais S. Miron M.J. de Moerloose P. Lepage R. Slosman D. Didier D. Unger P.F. Patenaude J.V. Bounameaux H. (1999) Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet, 353, 190 195.
83. Perrier A. Roy P.M. Aujesky D. Chagnon I. Howarth N. Gourdier A.L. Leftheriotis G. Barghouth G. Cornuz J. Hayoz D. Bounameaux H. (2004) Diagnosing pulmonary embolism in outpatients with clinical assessment, d-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. The American Journal of Medicine, 116, 291 299.
84. Perrier A. Roy P.M. Sanchez O. Le Gal G. Meyer G. Gourdier A.L. Furber A. Revel M.P. Howarth N. Davido A. Bounameaux H. (2005) Multidetector-row computed tomography in suspected pulmonary embolism. The New England Journal of Medicine, 352, 1760 1768.
85. Plate G. Ohlin P. Eklof B. (1985) Pulmonary embolism in acute iliofemoral venous thrombosis. The British Journal of Surgery, 72, 912 915.
86. Ponchon M. Goffette P. Hainaut P. (1999) Temporary vena caval filtration. Preliminary clinical experience with removable vena caval filters. Acta Clinica Belgica, 54, 223 228.
87. Prandoni P. Lensing A.W. Buller H.R. Carta M. Cogo A. Vigo M. Casara D. Ruol A. ten Cate J.W. (1992) Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet, 339, 441 445.
88. Prandoni P. Lensing A.W. Piccioli A. Bernardi E. Simioni P. Girolami B. Marchiori A. Sabbion P. Prins M.H. Noventa F. Girolami A. (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, 100, 3484 3488.
89. PREPIC Study Group (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 112, 416 422.
90. Pruszczyk P. Torbicki A. Pacho R. Chlebus M. Kuch-Wocial A. Pruszynski B. Gurba H. (1997) Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs spiral CT. Chest, 112, 722 728.
91. Quinlan D.J. McQuillan A. Eikelboom J.W. (2004) Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Annals of Internal Medicine, 140, 175 183.
92. Refuerzo J.S. Hechtman J.L. Redman M.E. Whitty J.E. (2003) Venous thromboembolism during pregnancy. Clinical suspicion warrants evaluation. The Journal of Reproductive Medicine, 48, 767 770.
93. Sakuragi T. Sakao Y. Furukawa K. Rikitake K. Ohtsubo S. Okazaki Y. Natsuaki M. Itoh T. (2003) Successful management of acute pulmonary embolism after surgery for lung cancer. European Journal of Cardio-Thoracic Surgery, 24, 580 587.
94. Savi P. Chong B. Greinacher A. Gruel Y. Kelton J.G. Warkentin T.E. Eichler P. Meuleman D. Petitou M. Herault J.P. Cariou R. Herbert J.M. (2004) Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies. A blinded comparative multicenter study with unfractionated heparin. Blood, 105, 139 144.
95. Schmitt B.P. Adelman B. (1993) Heparin-associated thrombocytopenia: a critical review and pooled analysis. The American Journal of the Medical Sciences, 305, 208 215.
96. Schulman S. Wahlander K. Lundstrom T. Clason S.B. Eriksson H. (2003) Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. The New England Journal of Medicine, 349, 1713 1721.
97. Silverstein M.D. Heit J.A. Mohr D.N. Petterson T.M. O'Fallon W.M. Melton L.J. Jr. (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Archives of Internal Medicine, 158, 585 593.
98. Stein P.D. Saltzman H.A. Weg J.G. (1991) Clinical characteristics of patients with acute pulmonary embolism. The American Journal of Cardiology, 68, 1723 1724.
99. Stein P.D. Athanasoulis C. Alavi A. Greenspan R.H. Hales C.A. Saltzman H.A. Vreim C.E. Terrin M.L. Weg J.G. (1992) Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation, 85, 462 468.
100. Stein P.D. Kayali F. Olson R.E. (2004) Regional differences in rates of diagnosis and mortality of pulmonary thromboembolism. The American Journal of Cardiology, 93, 1194 1197.
101. Ten Wolde M. Hagen P.J. Macgillavry M.R. Pollen I.J. Mairuhu A.T. Koopman M.M. Prins M.H. Hoekstra O.S. Brandjes D.P. Postmus P.E. Buller H.R. (2004) Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study. Journal of Thrombosis and Haemostasis, 2, 1110 1117.
102. The PIOPED Investigators (1990) Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA, 263, 2753 2759.
103. The Urokinase Pulmonary Embolism Trial Investigators (1973) The urokinase pulmonary embolism trial. A national cooperative study. Circulation, 47 (Suppl. 2 II1 108.
104. Toglia M.R. Weg J.G. (1996) Venous thromboembolism during pregnancy. The New England Journal of Medicine, 335, 108 114.
105. Torbicki A. Kurzyna M. Ciurzynski M. Pruszczyk P. Pacho R. Kuch-Wocial A. Szulc M. (1999) Proximal pulmonary emboli modify right ventricular ejection pattern. The European Respiratory Journal, 13, 616 621.
106. Turkstra F. Koopman M.M. Buller H.R. (1997) The treatment of deep vein thrombosis and pulmonary embolism. Thrombosis and Haemostasis, 78, 489 496.
107. Turpie A.G. Bauer K.A. Eriksson B.I. Lassen M.R. (2002) Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet, 359, 1721 1726.
108. Ullmann M. Hemmer W. Hannekum A. (1999) The urgent pulmonary embolectomy: mechanical resuscitation in the operating theatre determines the outcome. The Thoracic Cardiovascular Surgeon, 47, 5 8.
109. Van Strijen M.J. De Monye W. Kieft G.J. Pattynama P.M. Prins M.H. Huisman M.V. (2005) Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy. Journal of Thrombosis and Haemostasis, 3, 17 25.
110. Visentin G.P. Ford S.E. Scott J.P. Aster R.H. (1994) Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. The Journal of Clinical Investigation, 93, 81 88.
111. Warkentin T.E. (2003) Heparin-induced thrombocytopenia: pathogenesis and management. British Journal of Haematology, 121, 535 555.
112. Warkentin T.E. Levine M.N. Hirsh J. Horsewood P. Roberts R.S. Gent M. Kelton J.G. (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. The New England Journal of Medicine, 332, 1330 1335.
113. Weitz J.I. (1990) Mechanism of action of the thrombolytic agents. Bailliere's Clinical Haematology, 3, 583 599.
114. Wellons E.D. Rosenthal D. Shuler F.W. Levitt A.B. Matsuura J. Henderson V.J. (2004) Real-time intravascular ultrasound-guided placement of a removable inferior vena cava filter. The Journal of Trauma, 57, 20 23 discussion 23-25.
115. Wells P.S. Buller H.R. (2001) Outpatient treatment of patients with pulmonary embolism. Seminars in Vascular Medicine, 1, 229 234.
116. Wells P.S. Ginsberg J.S. Anderson D.R. Kearon C. Gent M. Turpie A.G. Bormanis J. Weitz J. Chamberlain M. Bowie D. Barnes D. Hirsh J. (1998a) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Annals of Internal Medicine, 129, 997 1005.
117. Wells P.S. Kovacs M.J. Bormanis J. Forgie M.A. Goudie D. Morrow B. Kovacs J. (1998b) Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Archives of Internal Medicine, 158, 1809 1812.
118. Wells P.S. Anderson D.R. Rodger M. Ginsberg J.S. Kearon C. Gent M. Turpie A.G. Bormanis J. Weitz J. Chamberlain M. Bowie D. Barnes D. Hirsh J. (2000) Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thrombosis and Haemostasis, 83, 416 420.
119. Wells P.S. Anderson D.R. Rodger M. Stiell I. Dreyer J.F. Barnes D. Forgie M. Kovacs G. Ward J. Kovacs M.J. (2001) Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Annals of Internal Medicine, 135, 98 107.
120. Westermark N. (1938) On the roentgen diagnosis of lung embolism. Acta Radiologica, 19, 357 372.
121. White R.H. (2003) The epidemiology of venous thromboembolism. Circulation, 107, I4 I8.
122. White R.H. Gettner S. Newman J.M. Trauner K.B. Romano P.S. (2000) Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. The New England Journal of Medicine, 343, 1758 1764.
123. Wicki J. Perneger T.V. Junod A.F. Bounameaux H. Perrier A. (2001) Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Archives of Internal Medicine, 161, 92 97.
124. Winer-Muram H.T. Boone J.M. Brown H.L. Jennings S.G. Mabie W.C. Lombardo G.T. (2002) Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology, 224, 487 492.
125. Wood K.E. (2002) Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest, 121, 877 905.